Vukmir & Associates has advised Erste & Steiermarkische Bank d.d. and Zagrebacka banka d.d. on their provision of a EUR 24 million club loan to the Arena Hospitality Group.

Boyanov & Co, working with the London office of White & Case, has advised the initially mandated lead arranger, the general security agent, the Bulgarian security agent on EUR 360 million facilities to Eastern European Electric Company B.V. Djingov, Gouginski, Kyutchukov & Velichkov advised the agent and lender Metric Capital Partners on a mezzanine facility provided to the company.

Schoenherr, working with Latham & Watkins and Orrick Herrington & Sutcliffe, and has advised French diagnostic center group Cerba HealthCare on the acquisition of the Lifebrain Group from Investindustrial. Chiomenti and Wolf Theiss advised Investindustrial on the deal.

Linklaters has advised Bain Capital Credit on a strategic joint venture with White Star Group. The joint venture will invest in logistics projects in Poland and the CEE. Dentons advised White Star Group on the deal.

NNDKP has successfully represented companies that are part of the Efacec Group before the Court of International Commercial Arbitration attached to the Chamber of Commerce and Industry of Romania against local administrative authority Braila County.

Sayenko Kharenko and Turcan Cazac advised joint bookrunners Citigroup, ING, and Renaissance Capital on the tap issue of USD 50 million 8.45% secured notes due 2026 by Trans-Oil Group. Baker McKenzie and Gladei & Partners advised Trans-Oil Group. 

Sorainen has advised Tallinn-based Temnikova & Kasela art gallery on a non-fungible token project.

Soltysinski, Kawecki & Szlezak, working with Winston & Strawn, has advised Los Angeles-based investment firm Diversis Capital on the acquisition of image recognition platform developer Shelfwise. Chabasiewicz Kowalska, working with Pillsbury Winthrop Shaw Pittman, represented the sellers on the deal.

Alrud has represented French automobile educational association GNFA in a corporate dispute with a former minority shareholder, an unidentified Russian company.

Linklaters has advised industrial and warehouse developer Panattoni on its lease of logistics spaces to DHL Supply Chain and MidOcean. Nikiel Wojcik Noworyta advised MidOcean on the deal.

Kocian Solc Balastik has advised Solitea on its acquisition of Mainstream Technologies and its parent company Powerstream. Oswaldova & Partners Advokatni Kancelar reportedly advised the seller.

Bryan Cave Leighton Paisner, working with Uzbekistan-based co-counsel Kosta Legal, has advised Sberbank on its sale of 84.2% of the shares in JSC Akhangarancement. Legate and, reportedly, EPAM advised the unidentified buyer.

Grzegorz Godlewski has joined WKB as Partner in the firm's M&A team.

Mihaela Gherghe has been promoted to Partner with Rizoiu & Poenaru.

Former Senior Associate Agnieszka Starzynska has been promoted to Counsel at CMS’s Polish office and will head the firm’s Life Sciences and Healthcare Practice.

Former Managing Associates Liliana Deaconescu and Corina Tanase have been promoted to Partner at Leaua Damcali Deaconu Paunescu.

Former Baker McKenzie Senior Counsel Georg Krakow joins DLA Piper’s white-collar crime, compliance, and internal investigations team in Vienna as Partner, alongside a team of four.

Sertac Kokenek has been promoted to Partner at Esin Attorney Partnership, Baker McKenzie’s Turkish affiliated firm.

Former CMS Russia Head of M&A Vladimir Zenin has joined Squire Patton Boggs as a Partner of the firm’s Global Corporate Practice, based in the Moscow office. He is followed by a team of three Associates. 

Malgorzata Lesiak-Cwikowska and Radoslaw Cebelinski have been promoted to Local Partners at DWF in Poland.

Dispute resolution lawyer Cosmin Cojocaru has been promoted to Partner at Zamfirescu Racoti Vasile & Partners.

Aleksandra Bankowska and Andrzej Zubik have been promoted to Partner in PwC's Legal & Tax Litigation cluster in Poland. 

Former Noerr Associate Partner Roxana Dudau has joined EY-associated law firm Radu si Asociatii as Associate Partner and Head of the Real Estate Practice.

Former Kinstellar Partner Razvan Popa has set up business advisory company Dewi Advisory, a "growth advisory company focused on [the] Romanian market."

YES - In its previous case law, the court has recognised the importance of hyperlinks for the operation of the World Wide Web and for freedom of speech. On these grounds, the European Court of Justice (ECJ) generously allowed the use of links to make third-party content accessible via one's own website.

In July, new Arbitration and Mediation Rules of the Vienna International Arbitration Centre ("VIAC" and "VIAC Rules") entered into force. The revised VIAC Rules will apply to arbitrations commenced after 30 June 2021.

The pharmaceutical sector in Kosovo is undergoing three major policy and legal reforms to increase its competitiveness and transparency. These reforms are part of a national project to improve the underdeveloped and under-regulated pharmaceutical market which would, in turn, encourage increased spending in the healthcare and pharmaceutical sector.

The Law on Medication and Medical Devices (Official Gazette no. 58/08) and the Rulebook on Manner of Marketing of Medicines and Medical Devices (Official Gazette no. 40/10) regulate the advertising of medicines and medical devices in Bosnia & Herzegovina.

Not all the impacts of the COVID-19 crisis on Romanian society are negative. The crisis also led to the much-overdue regulation of telemedicine in Romania.

During the COVID-19 pandemic, the Healthcare/Pharma/Life Sciences sector has, not surprisingly, come into focus, with the production licencing and supply of vaccines and the ability of hospitals and healthcare facilities to operate and the production of healthcare products all attracting attention.

A freely-accessible public healthcare system has always been considered one of the pillars of the modern welfare state. However, the dearth of adequate managerial skills and advance planning within the healthcare framework has often led to systemic problems, like issues with financing for a system that is regarded as a public service by users and a private business by service suppliers. This problem has once again resurfaced in the Croatian health sector, with debts accumulated by public hospitals and pharmacies standing in the way of a regular supply of medicinal products and medical devices by manufacturers, wholesalers, and pharmacies.

As a large country with a population of over 82 million and a comprehensive public and private healthcare system designed to provide an accessible and equitable medical service to each and every person living in Turkey, the potential for every life science-related sector in the country could easily be deemed as advanced.

The fundamental goal of each company is to increase sales. For this purpose, players that operate in the Ukrainian pharma market utilize a wide range of promotional activities. However, Ukrainian laws on health protection allow very few of them when it comes to prescription (or “Rx”) pharmaceuticals.

The COVID-19 pandemic has accelerated the digital evolution of clinical trials. Introducing new technologies and ways of working with clinical data, improving clinical data access, review, and monitoring processes, and making better use of the data for further scientific research are trends that are here to stay. Side by side with these developments come legal questions about personal data protection. The aim of this article is to shed light on the core legal issue in data processing within clinical trials: its legal basis.

[Updated on 8 July 2021] Further to the entry into force of EU Medical Devices Regulation 2017/745 on May 26 2021, the Romanian Government issued an Emergency Ordinance setting forth the institutional framework for ensuring the MDR’s direct application (“GEO no. 46/2021”) and announced that the Ministry of Health will issue the secondary legislation in the following months.

For at least the last 15 years, co-promotion and co-marketing agreements between pharmaceutical companies have been valuable instruments for cost-effective marketing of pharmaceutical products. Both types of agreement are used both locally and globally to effectively allocate the skills and expertise of marketing teams based on product type, therapeutic category, and product maturity.